Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Clinical Breast Cancer|May 21, 2003
Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trialAman BuzdarThe Oncologist|January 6, 2005
How rapidly do oncologists respond to clinical trial data?Aman Buzdar, Cynthia MacahiligThe Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman BuzdarThe Surgical Clinics of North America|July 24, 2003
The current status of aromatase inhibitors in the management of breast cancerMichael Baum, Aman BuzdarSeminars in Oncology|July 26, 2002
Recent advances in aromatase inhibitor therapy for breast cancerVasily J Assikis, Aman BuzdarClinical Therapeutics|December 25, 2003
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancerW Robert Simons, David Jones, Aman BuzdarThe Journal of Pain|July 15, 2009
Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxelCielito C Reyes-Gibby, Phuong Khang Morrow, Aman Buzdar, et al.Current Medical Research and Opinion|July 28, 2006
Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancerAman Buzdar, Rowan Chlebowski, Jack Cuzick, et al.The Lancet. Oncology|December 18, 2007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, John F Forbes, Jack Cuzick, et al.The Lancet. Oncology|November 20, 2010
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trialJack Cuzick, Ivana Sestak, Michael Baum, et al.Pageof 3